Uploaded November 2026 | Updated November 2026, 7 hours ago
Proteogenomics is poised to enter a new era, where insights from global population studies can illuminate biology that smaller or narrower cohorts could not reveal. This panel will examine what proteogenomics in global populations means for researchers working across different scientific and translational contexts, and why it matters for discovery and patient impact. Panelists will share examples where combining genomic and proteomic data across large, international populations has uncovered novel biology and new disease mechanisms that were previously overlooked. The discussion will touch on multi-omics approaches to complex conditions such as obesity and metabolism, efforts to address underrepresentation in African cohorts, and strategies to build the next generation of population-based studies. Finally, the panel will explore how academic–industry collaborations can accelerate progress, and how global population proteogenomics can help fulfill the urgent mandate to deliver what patients need next.
Speakers:
Mark McCarthy, MB, BChir, MD, FRCP - Senior Director, Staff Scientist, Genentech
Dr. Oyesola Ojewunmi - Senior Research Fellow in Genomics, Queen Mary Universi...
Cindy Lawley, PhD - Sr Director, Population Health Olink Proteomics
Michael Förster, PhD - Senior Medical Science Liaison, Olink, part of Thermo Fisher Scientific
Proteogenomics is poised to enter a new era, where insights from global population studies can illuminate biology that smaller or narrower cohorts could not reveal. This panel will examine what proteogenomics in global populations means for researchers working across different scientific and translational contexts, and why it matters for discovery and patient impact. Panelists will share examples where combining genomic and proteomic data across large, international populations has uncovered novel biology and new disease mechanisms that were previously overlooked. The discussion will touch on multi-omics approaches to complex conditions such as obesity and metabolism, efforts to address underrepresentation in African cohorts, and strategies to build the next generation of population-based studies. Finally, the panel will explore how academic–industry collaborations can accelerate progress, and how global population proteogenomics can help fulfill the urgent mandate to deliver what patients need next.
Speakers:
Mark McCarthy, MB, BChir, MD, FRCP - Senior Director, Staff Scientist, Genentech
Dr. Oyesola Ojewunmi - Senior Research Fellow in Genomics, Queen Mary Universi...
Cindy Lawley, PhD - Sr Director, Population Health Olink Proteomics
Michael Förster, PhD - Senior Medical Science Liaison, Olink, part of Thermo Fisher Scientific










